Economic evaluation clinical trials




















References 1. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: Clinical effectiveness. II: Cost effectiveness. Drummond M. Economic analysis alongside controlled trials. London: Department of Health; O'Brien B. Economic evaluation of pharmaceuticals: Frankenstein's monster or vampire of trials?

Medical Care. Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. Sample size and power calculations for stochastic cost-effectiveness analysis. Med Decision Making. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med. Estimation rather than hypothesis testing: confidence intervals rather than P values.

Statistics with confidence. A solid cost-benefit analysis is essential to justify the high price and development cost of many medicines and medical devices.

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Academic Skip to main content. Search Start Search. Choose your country or region Close.

Dear Customer, As a global organization, we, like many others, recognize the significant threat posed by the coronavirus. Please contact our Customer Service Team if you have any questions. Glick, Jalpa A. Doshi, and Seema S. Sonnad Edited by Daniel Polsky Handbooks in Health Economic Evaluation A practical guide to designing and conducting appropriate, rigorous economic evaluations of clinical trials Hugely important for anyone involved in the development of new drugs, therapies, or devices Supporting material provided online.

Also of Interest. At What Cost Nicholas Freudenberg. Prevention Diaries Larry Cohen. Gray, Philip M. Published by Elsevier Inc. All rights reserved. Abstract Objectives: Amid a rapid increase in cancer care costs, we examined the extent to which economic evaluations EEs were conducted for new treatments evaluated in clinical trials at SWOG, a large National Cancer Institute-sponsored cancer research network. Publication types Research Support, N.

Gov't Review.



0コメント

  • 1000 / 1000